Get the Stockscreener App
3.93
5.76%
-0.24
After Hours:
4.05
0.12
+3.05%
Larimar Therapeutics Inc stock is traded at $3.93, with a volume of 1.30M.
It is down -5.76% in the last 24 hours and up +6.22% over the past month.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
See More
Previous Close:
$4.17
Open:
$4.16
24h Volume:
1.30M
Relative Volume:
0.94
Market Cap:
$336.37M
Revenue:
-
Net Income/Loss:
$-36.95M
P/E Ratio:
-4.6786
EPS:
-0.84
Net Cash Flow:
$-33.46M
1W Performance:
-0.25%
1M Performance:
+6.22%
6M Performance:
+46.10%
1Y Performance:
-45.72%
1-Day Range:
$3.90
$4.17
1-Week Range:
$3.78
$4.2606
52-Week Range:
$1.61
$9.50
Larimar Therapeutics Inc Stock (LRMR) Company Profile
Name
Larimar Therapeutics Inc
Sector
Industry
Phone
844-511-9056
Address
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA
Compare LRMR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LRMR
Larimar Therapeutics Inc
|
3.93 | 342.36M | 0 | -36.95M | -33.46M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Larimar Therapeutics Inc Stock (LRMR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-25 | Initiated | Truist | Buy |
| Oct-16-24 | Initiated | Oppenheimer | Outperform |
| Oct-03-24 | Initiated | Wedbush | Outperform |
| Oct-02-24 | Initiated | H.C. Wainwright | Buy |
| Sep-04-24 | Initiated | Robert W. Baird | Outperform |
| Apr-03-24 | Initiated | Leerink Partners | Outperform |
| Nov-17-23 | Upgrade | Citigroup | Neutral → Buy |
| Oct-19-22 | Initiated | Guggenheim | Buy |
| Feb-15-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-10-21 | Initiated | JMP Securities | Mkt Outperform |
| Feb-01-21 | Initiated | William Blair | Outperform |
View All
Larimar Therapeutics Inc Stock (LRMR) Latest News
How to read the order book for Larimar Therapeutics Inc.2025 Top Gainers & Free Technical Pattern Based Buy Signals - Newser
Combining machine learning predictions for Larimar Therapeutics Inc.Market Trend Report & Long-Term Capital Growth Ideas - Newser
Published on: 2025-09-12 17:24:42 - Newser
How to use Fibonacci retracement on Larimar Therapeutics Inc.Day Trade & Weekly Breakout Watchlists - Newser
tools to monitor larimar therapeutics inc. recovery probabilitySwing Trade & AI Driven Stock Price Forecasts - Newser
What high frequency data says about Larimar Therapeutics Inc.2025 Retail Activity & Long-Term Growth Stock Strategies - Newser
How to integrate Larimar Therapeutics Inc. into portfolio analysis toolsLong Setup & Weekly Watchlist of Top Performers - Newser
Is Larimar Therapeutics Inc. forming a reversal patternStop Loss & Stepwise Swing Trade Plans - Newser
How high can Larimar Therapeutics Inc. stock goPortfolio Update Summary & Risk Managed Trade Strategies - Newser
Published on: 2025-09-12 05:19:01 - Newser
Historical volatility pattern of Larimar Therapeutics Inc. visualizedBond Market & Real-Time Stock Movement Alerts - Newser
Real time pattern detection on Larimar Therapeutics Inc. stockQuarterly Investment Review & Weekly High Potential Alerts - Newser
Cubist Systematic Strategies LLC Has $762,000 Stock Holdings in Larimar Therapeutics, Inc. $LRMR - MarketBeat
how high can larimar therapeutics inc. stock goWeekly Market Outlook & Free Weekly Chart Analysis and Trade Guides - Newser
Is Larimar Therapeutics Inc. still worth holding after the dipJuly 2025 Patterns & Fast Entry and Exit Trade Plans - Newser
Tools to monitor Larimar Therapeutics Inc. recovery probabilityBull Run & Weekly Top Gainers Trade List - Newser
Leerink Partnrs Has Bearish Outlook for LRMR FY2025 Earnings - MarketBeat
Alyeska Investment Group L.P. Has $3.10 Million Stock Holdings in Larimar Therapeutics, Inc. $LRMR - MarketBeat
Earnings visualization tools for Larimar Therapeutics Inc.2025 Key Highlights & Detailed Earnings Play Alerts - Newser
Momentum divergence signals in Larimar Therapeutics Inc. chartWeekly Loss Report & High Return Stock Watch Alerts - Newser
Volume spikes in Larimar Therapeutics Inc. stock – what they meanRecession Risk & Verified Entry Point Detection - Newser
Published on: 2025-09-11 17:34:16 - Newser
Published on: 2025-09-11 15:27:49 - Newser
News impact scoring models applied to Larimar Therapeutics Inc.Market Activity Report & Free Technical Confirmation Trade Alerts - Newser
Analyzing recovery setups for Larimar Therapeutics Inc. investorsTrade Entry Summary & Safe Capital Allocation Plans - Newser
Published on: 2025-09-11 02:16:21 - Newser
Order flow analysis tools used on Larimar Therapeutics Inc.July 2025 PostEarnings & Technical Confirmation Alerts - Newser
Nuveen LLC Takes $376,000 Position in Larimar Therapeutics, Inc. $LRMR - MarketBeat
Does Larimar Therapeutics Inc. fit your quant trading modelCEO Change & Free AI Powered Buy and Sell Recommendations - Newser
Sentiment analysis tools applied to Larimar Therapeutics Inc.Weekly Profit Analysis & Real-Time Chart Pattern Alerts - Newser
Analyzing net buyer seller activity in Larimar Therapeutics Inc.Weekly Trade Summary & Low Risk Growth Stock Ideas - Newser
Relative strength of Larimar Therapeutics Inc. in sector analysisBull Run & Risk Controlled Stock Pick Alerts - Newser
Visual trend scoring systems applied to Larimar Therapeutics Inc.Quarterly Profit Summary & AI Enhanced Trade Execution Alerts - Newser
Using data tools to time your Larimar Therapeutics Inc. exitMarket Sentiment Review & Daily Momentum Trading Reports - Newser
Using fundamentals and technicals on Larimar Therapeutics Inc.Weekly Gains Summary & Weekly Sector Rotation Insights - Newser
Smart tools for monitoring Larimar Therapeutics Inc.’s price actionTrade Analysis Summary & Verified Stock Trade Ideas - Newser
Will Larimar Therapeutics Inc. stock recover after recent dropTrade Exit Summary & Risk Controlled Stock Alerts - Newser
How sentiment analysis helps forecast Larimar Therapeutics Inc.July 2025 Action & High Accuracy Swing Entry Alerts - Newser
Published on: 2025-09-09 00:28:06 - Newser
Larimar Therapeutics Inc Stock (LRMR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):